medicine
Science
Patients Are Left With Few Options as GLP-1 Copycats Disappear
By Emily Mullin and Kate Knibbs
Business
OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation
By Zoë Schiffer, Emily Mullin, and Will Knight
Business
Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
By Kate Knibbs and Emily Mullin
Business
Thousands of Urine and Tissue Samples Are in Danger of Rotting After Staff Cuts at a CDC Laboratory
By Caroline Haskins
Science
Doctor Behind Award-Winning Parkinson’s Research Among Scientists Purged From NIH
By Dell Cameron and Emily Mullin